Grants and Contributions:

Title:

Commercial Level Validation (Per Health Canada’s Requirements) of a Set of Analytical Methods for Measuring the Quantity of multiple Active ingredients (Cannabinoids) in Selected Cannabis Derived Product Matrices Designed for Therapeutic Use

Agreement Number:

977217

Agreement Value:

$48,871.00

Agreement Date:

Jul 27, 2021 - Dec 3, 2021

Description:

This project will result in the validation, to a degree acceptable for commercialization as an analytical service, of a set of analytical methods for measuring the quality of selected cannabinoid containing edibles and topicals designed for therapeutic use. Quality in this context refers to the cannabinoid content of the products, as the acknowledged active ingredient(s).

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Toronto, Ontario, CA M1P 2G6

Reference Number:

172-2021-2022-Q2-977217

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

735907297

Recipient Type:

For-profit organization

Recipient's Legal Name:

Sigma Analytical Services Inc.

Federal Riding Name:

Scarborough Centre

Federal Riding Number:

35094

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54138